| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Canada | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Grindrod Scott | 15 |
| #2 | Jung Mira | 15 |
| #3 | Dritschilo Anatoly | 14 |
| #4 | Brown Milton | 10 |
| #5 | Timofeeva Olga | 4 |
| #6 | Dritschild Anatoly | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN112004537A | Selective histone deacetylase inhibitors for the treatment of human diseases | |
| CA3049435A1 | Selective histone deacetylase inhibitors for the treatment of human disease | |
| WO2018129514A1 | Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation | |
| US2018044292A1 | Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof |